HHLR ADVISORS, LTD. - Q3 2020 holdings

$13.2 Billion is the total value of HHLR ADVISORS, LTD.'s 89 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 33.8% .

 Value Shares↓ Weighting
ZM SellZOOM VIDEO COMMUNICATIONS INcl a$2,356,214,000
+35.5%
5,012,049
-26.9%
17.85%
+12.3%
BGNE  BEIGENE LTDsponsored adr$1,567,474,000
+52.0%
5,472,2590.0%11.87%
+26.0%
JD BuyJD.COM INCspon adr cl a$1,242,151,000
+164.3%
16,005,041
+104.9%
9.41%
+119.0%
BABA BuyALIBABA GROUP HLDG LTDsponsored ads$1,188,303,000
+40.2%
4,042,123
+2.9%
9.00%
+16.2%
IQ SellIQIYI INCsponsored ads$887,447,000
-18.0%
39,302,362
-15.8%
6.72%
-32.1%
PDD BuyPINDUODUO INCsponsored ads$756,784,000
-10.6%
10,206,116
+3.5%
5.73%
-25.9%
UBER  UBER TECHNOLOGIES INC$702,630,000
+17.4%
19,260,7000.0%5.32%
-2.7%
CBPO  CHINA BIOLOGIC PRODS HLDGS I$329,205,000
+8.8%
2,962,0760.0%2.49%
-9.9%
TAL SellTAL EDUCATION GROUPsponsored ads$313,198,000
-42.1%
4,118,862
-47.9%
2.37%
-52.0%
BEKE NewKE HLDGS INCsponsored ads$306,500,0005,000,000
+100.0%
2.32%
ESGR  ENSTAR GROUP LIMITED$282,276,000
+5.7%
1,747,8400.0%2.14%
-12.4%
GDS BuyGDS HLDGS LTDsponsored ads$257,243,000
+4741.8%
3,143,623
+4613.1%
1.95%
+3877.6%
CRM BuySALESFORCE COM INC$248,378,000
+86.9%
988,295
+39.3%
1.88%
+54.8%
BBIO  BRIDGEBIO PHARMA INC$176,779,000
+15.1%
4,711,6040.0%1.34%
-4.6%
BILI SellBILIBILI INCspons ads rep z$167,857,000
-60.2%
4,035,035
-55.7%
1.27%
-67.0%
FGEN  FIBROGEN INC$162,662,000
+1.5%
3,955,7870.0%1.23%
-16.0%
APLS  APELLIS PHARMACEUTICALS INC$151,703,000
-7.6%
5,028,2890.0%1.15%
-23.5%
ALGN SellALIGN TECHNOLOGY INC$129,367,000
-40.4%
395,183
-50.0%
0.98%
-50.6%
MDLZ SellMONDELEZ INTL INCcl a$127,841,000
+2.8%
2,225,264
-8.5%
0.97%
-14.8%
BPMC  BLUEPRINT MEDICINES CORP$126,501,000
+18.8%
1,364,6310.0%0.96%
-1.5%
ARGX  ARGENX SEsponsored adr$123,384,000
+16.6%
470,0000.0%0.94%
-3.4%
SNOW NewSNOWFLAKE INCcl a$105,420,000420,000
+100.0%
0.80%
ZTO SellZTO EXPRESS CAYMAN INCsponsored ads a$100,097,000
-20.6%
3,345,475
-2.6%
0.76%
-34.2%
MYOK  MYOKARDIA INC$94,157,000
+41.1%
690,6580.0%0.71%
+16.9%
GOSS  GOSSAMER BIO INC$92,094,000
-4.5%
7,420,9740.0%0.70%
-20.9%
BEAM  BEAM THERAPEUTICS INCcl a$73,033,000
-12.1%
2,966,4030.0%0.55%
-27.1%
IMAB NewI MABsponsored ads$70,382,0001,496,540
+100.0%
0.53%
VIE SellVIELA BIO INC$69,572,000
-43.0%
2,477,631
-12.0%
0.53%
-52.7%
GMAB  GENMAB A/Ssponsored ads$54,915,000
+8.0%
1,500,0000.0%0.42%
-10.5%
NIO NewNIO INCspon ads$51,177,0002,411,750
+100.0%
0.39%
AKRO BuyAKERO THERAPEUTICS INC$51,009,000
+93.7%
1,656,673
+56.8%
0.39%
+60.2%
KNSA BuyKINIKSA PHARMACEUTICALS LTD$44,735,000
-28.2%
2,920,023
+19.5%
0.34%
-40.4%
NVAX BuyNOVAVAX INC$41,732,000
+53.6%
385,158
+18.1%
0.32%
+27.4%
OTIS  OTIS WORLDWIDE CORP$38,361,000
+9.8%
614,5560.0%0.29%
-8.8%
TSM SellTAIWAN SEMICONDUCTOR MFG LTDsponsored ads$32,468,000
-48.0%
400,495
-63.6%
0.25%
-56.9%
Z NewZILLOW GROUP INCcl c cap stk$30,714,000302,336
+100.0%
0.23%
ALLO  ALLOGENE THERAPEUTICS INC$30,168,000
-11.9%
800,0000.0%0.23%
-26.8%
MELI NewMERCADOLIBRE INC$29,795,00027,525
+100.0%
0.23%
LI NewLI AUTO INCsponsored ads$29,057,0001,670,931
+100.0%
0.22%
MLCO  MELCO RESORTS AND ENTMNT LTDadr$28,286,000
+7.3%
1,698,8770.0%0.21%
-11.2%
IGMS  IGM BIOSCIENCES INC$25,834,000
+1.1%
350,0000.0%0.20%
-16.2%
BEDU  BRIGHT SCHOLAR ED HLDGS LTDsponsored ads$25,469,000
-18.7%
3,985,7970.0%0.19%
-32.5%
FMTX  FORMA THERAPEUTICS HLDGS INC$24,920,000
+7.2%
500,0000.0%0.19%
-10.8%
MOGU  MOGU INCspon ads$24,550,000
+30.6%
10,446,9700.0%0.19%
+8.1%
AMG  AFFILIATED MANAGERS GROUP IN$22,912,000
-8.3%
335,0730.0%0.17%
-23.7%
PRLD NewPRELUDE THERAPEUTICS INC$22,598,000750,000
+100.0%
0.17%
LEGN  LEGEND BIOTECH CORPsponsored ads$20,066,000
-27.5%
650,0000.0%0.15%
-39.9%
YY  JOYY INC$19,319,000
-8.9%
239,4760.0%0.15%
-24.7%
XPEV NewXPENG INCads$18,395,000916,518
+100.0%
0.14%
NKTX NewNKARTA INC$16,700,000555,556
+100.0%
0.13%
ADCT  ADC THERAPEUTICS SA$16,495,000
-29.5%
500,0000.0%0.12%
-41.6%
SOHU  SOHU COM LTDsponsored ads$15,928,000
+115.6%
802,0340.0%0.12%
+77.9%
BLI NewBERKELEY LTS INC$15,272,000200,000
+100.0%
0.12%
YALA NewYALLA GROUP LTDads$14,000,0002,000,000
+100.0%
0.11%
SE SellSEA LTDsponsored ads$13,497,000
-79.0%
87,622
-85.4%
0.10%
-82.6%
KDP BuyKEURIG DR PEPPER INC$13,360,000
+122.4%
484,068
+128.8%
0.10%
+83.6%
RGNX  REGENXBIO INC$12,549,000
-25.3%
456,0000.0%0.10%
-38.3%
GRUB  GRUBHUB INC$12,252,000
+2.9%
169,3860.0%0.09%
-14.7%
DYN NewDYNE THERAPEUTICS INC$12,114,000600,000
+100.0%
0.09%
RNA  AVIDITY BIOSCIENCES INC$11,964,000
-0.4%
425,0000.0%0.09%
-17.3%
GTHX  G1 THERAPEUTICS INC$10,966,000
-52.4%
949,4310.0%0.08%
-60.7%
RCUS  ARCUS BIOSCIENCES INC$10,713,000
-30.7%
625,0000.0%0.08%
-42.6%
BNR  BURNING ROCK BIOTECH LTDsponsored ads$10,032,000
-7.1%
400,0000.0%0.08%
-23.2%
TXG  10X GENOMICS INC$9,351,000
+39.6%
75,0000.0%0.07%
+16.4%
HOOK  HOOKIPA PHARMA INC$8,933,000
-18.5%
943,2540.0%0.07%
-32.0%
EIDX  EIDOS THERAPEUTICS INC$9,025,000
+6.0%
178,6000.0%0.07%
-12.8%
CVAC NewCUREVAC N V$8,667,000186,183
+100.0%
0.07%
ATNX NewATHENEX INC$8,773,000725,000
+100.0%
0.07%
CALT  CALLIDITAS THERAPEUTICS ABsponsered ads$8,400,000
+3.0%
350,0000.0%0.06%
-14.7%
ACMR NewACM RESEARCH INC$8,074,000116,841
+100.0%
0.06%
KYMR NewKYMERA THERAPEUTICS INC$8,078,000250,000
+100.0%
0.06%
ARVN SellARVINAS INC$7,378,000
-64.8%
312,500
-50.0%
0.06%
-70.8%
LPTX BuyLEAP THERAPEUTICS INC$7,358,000
-2.3%
3,716,240
+3.1%
0.06%
-18.8%
MRUS  MERUS N V$7,200,000
-25.4%
600,0000.0%0.06%
-37.5%
TCRR  TCR2 THERAPEUTICS INC$6,561,000
+32.3%
322,9030.0%0.05%
+11.1%
NXTC  NEXTCURE INC$5,617,000
-59.0%
638,3070.0%0.04%
-65.6%
HTHT  HUAZHU GROUP LTDsponsored ads$5,569,000
+23.4%
128,7860.0%0.04%
+2.4%
CJJD  CHINA JO-JO DRUGSTORES INC$4,694,000
-29.7%
4,840,0000.0%0.04%
-41.0%
FUTU NewFUTU HLDGS LTDspon ads cl a$4,293,000150,000
+100.0%
0.03%
CBMG  CELLULAR BIOMEDICINE GROUP I$4,314,000
+22.5%
235,2140.0%0.03%
+3.1%
MREO BuyMEREO BIOPHARMA GROUP PLCads$4,187,000
+996.1%
1,598,185
+1178.9%
0.03%
+966.7%
CVET  COVETRUS INC$3,785,000
+36.4%
155,1240.0%0.03%
+16.0%
PASG  PASSAGE BIO INC$3,286,000
-52.0%
250,6160.0%0.02%
-60.3%
DGNRU NewDRAGONEER GROWTH OPPORTUN COunit 08/18/2027$2,450,000200,000
+100.0%
0.02%
UXIN SellUXIN LTDads$1,998,000
-53.4%
2,297,318
-23.3%
0.02%
-61.5%
NEW  PUXIN LTDads$1,121,000
+72.2%
126,1450.0%0.01%
+33.3%
LEAPU NewRIBBIT LEAP LTDunit 99/99/9999$650,00050,000
+100.0%
0.01%
SFUN  FANG HLDGS LTDadr new$345,000
+1.5%
30,0000.0%0.00%0.0%
CIH  CHINA INDEX HLDGS LTDspnsrd ads a$435,000
-32.2%
300,0000.0%0.00%
-50.0%
API ExitAGORA INCads$0-30,050
-100.0%
-0.01%
ZLAB ExitZAI LAB LTDadr$0-400,000
-100.0%
-0.30%
LN ExitLINE CORPsponsored adr$0-676,211
-100.0%
-0.31%
VIPS ExitVIPSHOP HOLDINGS LIMITEDsponsored ads a$0-5,477,392
-100.0%
-1.00%
TSLA ExitTESLA INC$0-130,378
-100.0%
-1.29%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-11-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BEIGENE LTD20Q3 202326.0%
JD.COM INC20Q3 202313.1%
IQIYI INC20Q3 202312.3%
MONDELEZ INTL INC20Q3 20235.9%
KINIKSA PHARMACEUTICALS LTD20Q3 20231.6%
SOHU COM LTD20Q3 20230.6%
PINDUODUO INC19Q3 202316.1%
GOSSAMER BIO INC19Q3 20232.3%
BRIDGEBIO PHARMA INC18Q3 20233.4%
MELCO RESORTS AND ENTMT LTD18Q1 20232.8%

View HHLR ADVISORS, LTD.'s complete holdings history.

Latest significant ownerships (13-D/G)
HHLR ADVISORS, LTD. Q3 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
I-MabJune 30, 202315,891,2118.3%
BeiGene, Ltd.February 14, 2023147,043,05810.9%
Gossamer Bio, Inc.February 14, 20234,974,0415.3%
On Holding AGFebruary 14, 20235,468,5041.9%
Root, Inc.February 14, 2023138,9771.5%
Yatsen Holding LtdFebruary 14, 2023300,560,60219.1%
iQIYI, Inc.July 11, 2022149,075,9125.0%
Apellis Pharmaceuticals, Inc.February 14, 2022? ?
Beam Therapeutics Inc.February 14, 2022? ?
Futu Holdings LtdFebruary 14, 20222-

View HHLR ADVISORS, LTD.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
42024-02-01
13F-HR2023-11-14

View HHLR ADVISORS, LTD.'s complete filings history.

Compare quarters

Export HHLR ADVISORS, LTD.'s holdings